Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 23, 2014 - Issue 11
Submit an article Journal homepage
392
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Is there a need for new phosphate binders to treat phosphate imbalance associated with chronic kidney disease?

Jinshyun Ruth Wu-WongUniversity of Illinois, Department of Pharmacy Practice, 2201 W. Campbell Park Dr., Suite 13, Chicago, IL 60612, USA+1 847 863 9818; +1 847 680 6072; [email protected]
&
Masahide MizobuchiShowa University School of Medicine, Division of Nephrology, Department of Medicine, Tokyo, [email protected]
Pages 1465-1475 | Published online: 26 Jun 2014

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Valeria Cernaro, Domenico Santoro, Antonio Lacquaniti, Giuseppe Costantino, Luca Visconti, Antoine Buemi & Michele Buemi. (2016) Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide. International Journal of Nephrology and Renovascular Disease 9, pages 11-19.
Read now
J. Bover, P. Ureña-Torres, M. J. Lloret, C. Ruiz-García, I. DaSilva, M. M. Diaz-Encarnacion, C. Mercado, S. Mateu, E. Fernández & J. Ballarin. (2016) Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. Expert Opinion on Pharmacotherapy 17:9, pages 1247-1258.
Read now
Holger Schmid & Stephan R Lederer. (2015) Novel iron-containing phosphate binders for treatment of hyperphosphatemia. Expert Opinion on Pharmacotherapy 16:14, pages 2179-2191.
Read now

Articles from other publishers (2)

Mark Sampson, Nuno Faria & Jonathan J Powell. (2021) Efficacy and safety of PT20, an iron-based phosphate binder, for the treatment of hyperphosphataemia: a randomized, double-blind, placebo-controlled, dose-ranging, Phase IIb study in patients with haemodialysis-dependent chronic kidney disease. Nephrology Dialysis Transplantation 36:8, pages 1399-1407.
Crossref
Steven Habbous, Sebastian Przech, Janet Martin, Amit X. Garg & Sisira Sarma. (2018) Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease. Value in Health 21:3, pages 318-325.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.